ATE511836T1 - Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese - Google Patents

Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese

Info

Publication number
ATE511836T1
ATE511836T1 AT06758668T AT06758668T ATE511836T1 AT E511836 T1 ATE511836 T1 AT E511836T1 AT 06758668 T AT06758668 T AT 06758668T AT 06758668 T AT06758668 T AT 06758668T AT E511836 T1 ATE511836 T1 AT E511836T1
Authority
AT
Austria
Prior art keywords
light
skin carcinogenesis
suppressing skin
isothiocyanate
induced
Prior art date
Application number
AT06758668T
Other languages
English (en)
Inventor
Paul Talalay
Albena T Dinkova-Kostova
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE511836T1 publication Critical patent/ATE511836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06758668T 2005-04-29 2006-04-27 Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese ATE511836T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67584705P 2005-04-29 2005-04-29
US75034105P 2005-12-15 2005-12-15
PCT/US2006/016012 WO2006118941A1 (en) 2005-04-29 2006-04-27 Methods of supressing uv light-induced skin carcinogenesis

Publications (1)

Publication Number Publication Date
ATE511836T1 true ATE511836T1 (de) 2011-06-15

Family

ID=36722066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06758668T ATE511836T1 (de) 2005-04-29 2006-04-27 Verfahren zur unterdrückung von durch uv-licht induzierter hautcarcinogenese

Country Status (12)

Country Link
US (1) US20090247477A1 (de)
EP (1) EP1890683B1 (de)
JP (1) JP2008539261A (de)
KR (1) KR20080045083A (de)
CN (1) CN101208079B (de)
AT (1) ATE511836T1 (de)
AU (1) AU2006242528B2 (de)
CA (1) CA2606382C (de)
IL (1) IL186960A0 (de)
MX (1) MX2007013396A (de)
NZ (1) NZ563852A (de)
WO (1) WO2006118941A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1474158B1 (de) * 2001-12-18 2009-10-14 Brassica Foundation for Chemoprotection Research, Inc. Vorbeugung und behandlung von oxidativer-stress-erkrankungen mit verbindungen die den intrazellulären spiegel von glutathion oder phase-ii-entgiftungsenzymen erhöhen
EP2205237A1 (de) * 2007-10-16 2010-07-14 Johns Hopkins University Verfahren für den schutz der haut vor strahlungseinflüssen
CA2744388A1 (en) * 2008-11-21 2010-05-27 The Johns Hopkins University Compositions and methods for treating or preventing radiation injury
EP2229824A1 (de) 2009-03-12 2010-09-22 Nestec S.A. Kovalente Milchprotein/isothiocyanatkomplexe
DE102009058325A1 (de) * 2009-12-15 2011-06-16 Henning Vollert Brassica Extrakte zur Erhöhung des antioxidativen Potentials der Haut
US8927007B2 (en) * 2010-09-17 2015-01-06 Paul Talalay Formulations for treatment with glucosinolates
CA2831403A1 (en) * 2011-05-19 2012-11-22 Glax L.L.C. Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells
AU2013286721B2 (en) * 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
WO2014168736A1 (en) * 2013-03-15 2014-10-16 Nutramax Laboratories, Inc. Sulforaphane/sulforaphane precursor and phytosterol/phytostanol compositions
KR101515573B1 (ko) * 2014-11-07 2015-04-28 주식회사 파미니티 뉴그린 추출물을 유효성분으로 함유하는 해독용 조성물
US10154955B2 (en) 2016-07-01 2018-12-18 Access Business Group International Llc Compositions including bauhinia, methods of making and using the same in skin anti-aging and other skin applications
US12233073B2 (en) 2017-06-09 2025-02-25 Regents Of The University Of Minnesota Skin care formulations and skin cancer treatment
CN109588698A (zh) * 2017-09-30 2019-04-09 华中科技大学 一种防治酒精中毒性精神障碍的功能性食品和药品及其制法
CN110585049A (zh) * 2019-10-22 2019-12-20 赣州华汉生物科技有限公司 一种萝卜硫素防晒霜
JP7669208B2 (ja) * 2021-06-25 2025-04-28 カゴメ株式会社 グルコシノレート含有植物粉末、及びグルコシノレート含有植物粉末の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
AU5440901A (en) * 1999-12-20 2001-07-03 Cognis France, S.A. Cosmetic and/or pharmaceutical preparations
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
TW200407119A (en) * 2002-08-05 2004-05-16 Kin-Ping Wong Methods and compositions to treat conditions associated with neovascularization
DE10308298A1 (de) * 2003-02-26 2004-09-09 Kullmer, Thomas, Priv. Doz. Dr. med. Verfahren zur Herstellung von Präparationen mit hochkonzentrierten Brassica-Inhaltsstoffen und deren Verwendung

Also Published As

Publication number Publication date
AU2006242528A1 (en) 2006-11-09
EP1890683B1 (de) 2011-06-08
MX2007013396A (es) 2008-03-14
KR20080045083A (ko) 2008-05-22
AU2006242528B2 (en) 2012-09-20
NZ563852A (en) 2011-07-29
CN101208079A (zh) 2008-06-25
CA2606382A1 (en) 2006-11-09
JP2008539261A (ja) 2008-11-13
CN101208079B (zh) 2012-07-04
US20090247477A1 (en) 2009-10-01
IL186960A0 (en) 2008-02-09
CA2606382C (en) 2014-10-07
EP1890683A1 (de) 2008-02-27
WO2006118941A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
IL186960A0 (en) Methods of suppressing uv light-induced skin carcinogenesis
CO2022003582A2 (es) Métodos para el tratamiento de la oftalmopatía tiroidea
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
AR054094A1 (es) Tratamientos de cancer
CY1111177T1 (el) Ενωση φαινοθειαζινιου για επουλωση τραυματων
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
BRPI0519424A2 (pt) composiÇÕes e mÉtodos para tratamento de distérbios de proliferaÇço celular
BRPI0513866A (pt) composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
ATE387194T1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
CL2015000148A1 (es) Inmunoglobulina g variante porque comprende dos o mas sustituciones de aminoácidos; composición farmacéutica y kit que comprenden dicha inmunolobulina; uso de dicha inmunoglobulina para tratar tumor
BR112015022047A2 (pt) métodos para tratar câncer de bexiga
EA200900819A1 (ru) Хиназолины для ингибирования pdk1
ATE408412T1 (de) Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration
BRPI0617165B1 (pt) Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos
CY1109741T1 (el) Sns-595 και μεθοδοι χρησης αυτου
BRPI0902603A8 (pt) uso cosmético de pelo menos um composto ditiolano, composto ditiolano, composição e processo cosmético de preparação da pele para o sol
BRPI0915439A2 (pt) composição tópica para o tratamento de ceratose actínica
EP2054066A4 (de) Verfahren zur behandlung von strahlenenteritis
WO2015104292A3 (en) Compounds for use in treating or preventing cancerous diseases
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
MX2020013730A (es) Metodo para tratar el cancer mediante la combinacion de un inhibidor de iap y un modulador de una molecula de punto de control inmunitario.
MX387658B (es) Métodos para tratar y/o prevenir queratosis actínica.
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
EA200701995A1 (ru) Способы уменьшения кальцификации
ATE422873T1 (de) Kosmetische bzw. dermatologische präparate mit wirksamem lichtschutz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties